Quentin Pereira

Quentin Pereira has worked in a variety of roles in the fields of biotherapeutics, pharmaceuticals, facility management, research and civil engineering. In 2020, they began working as the Administrative and Financial Manager for Smartimmune. In 2019 they became the Financial Controller for Medday Pharmaceuticals. From 2016 to 2019, they worked as the Global Buyer and Data Analyst for Procurement and Facility Management at Sanofi. In 2016, they took on a Business Development Consultant role at STALLERGENES GREER. In 2015, they worked as an Associate Research Scientist at Sanofi. In 2014, they were an Associate Research Scientist at Yale University School of Medicine, where they conducted research into macular degeneration. In 2013, they were a Research Technician at IFSTTAR, where they studied atmospheric concrete carbonation.

Quentin Pereira has a well-rounded education history. Quentin began their studies in 2007, when they earned their Baccalauréat from Lycée Condorcet. From 2010 to 2012, they attended Lycée Louis Le Grand and earned a Classes Préparatoires aux Grandes Ecoles in PCSI - PC*. In 2013, they earned a Bachelor in Sciences in Chemistry from Ecole Nationale Supérieure de Chimie de Montpellier. Quentin then continued their studies at the same institution and earned a Graduate Studies in Organic Chemistry in 2014. That same year, they attended Lund University and studied Medicinal Chemistry. From 2015 to 2017, they attended HEC Paris and earned a Master Spécialisé HEC in Management de Grands Projets (MGP). In 2021, they earned a Certificat Directeur Financier (L-GF6000) from Francis Lefebvre Formation in Finance et services de gestion financière. Additionally, they have obtained two certifications, a Certificat Directeur Financier from Francis Lefebvre Formation in 2021 and a Master Spécialisé - MS Management de Grands Projets - HEC Paris - ISAE Supaéro in 2017.